{"entity":{"type":"insider","cik":"0001785288","url":"/insider/0001785288","json_url":"/insider/0001785288.json","name":"Lucchino David L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":101,"n_filings":48,"first":"2020-04-17","last":"2023-11-27","span_basis":"filed_date"},"name_variants":[{"name":"Lucchino David L.","source":"filing","n_filings":48,"first_seen":"2020-04-17","last_seen":"2023-11-27"}],"transactions":[{"id":8695625,"accession":"0000950170-23-066217","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-066217","line_url":"/filing/0000950170-23-066217","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Korro Bio, Inc.","issuer_ticker":"KRRO","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1156.0,"shares_display":"1,156","price_per_share":37.692523010380626,"price_display":"37.69","price_state":"stated","total_value":43572.5566,"total_display":"43,572.56","total_whole":"43,573","shares_owned_after":22352.0,"shares_owned_after_display":"22,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-27","scope":"insider","n_lines":4},{"id":8646264,"accession":"0000950170-23-065866","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950170-23-065866","line_url":"/filing/0000950170-23-065866","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Korro Bio, Inc.","issuer_ticker":"KRRO","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":968.0,"shares_display":"968","price_per_share":41.97499783057851,"price_display":"41.97","price_state":"stated","total_value":40631.7979,"total_display":"40,631.80","total_whole":"40,632","shares_owned_after":23864.0,"shares_owned_after_display":"23,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-10","filed_date":"2023-11-22","scope":"insider","n_lines":7},{"id":8413461,"accession":"0001127602-23-023081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-023081","line_url":"/filing/0001127602-23-023081#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3057.0,"shares_display":"3,057","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":1528.5,"total_display":"1,528.50","total_whole":"1,529","shares_owned_after":633744.0,"shares_owned_after_display":"633,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-22","scope":"insider"},{"id":8413457,"accession":"0001127602-23-023081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-023081","line_url":"/filing/0001127602-23-023081#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2865.0,"shares_display":"2,865","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":1719.0,"total_display":"1,719.00","total_whole":"1,719","shares_owned_after":636801.0,"shares_owned_after_display":"636,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-18","filed_date":"2023-08-22","scope":"insider"},{"id":7971155,"accession":"0001127602-23-022901","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-022901","line_url":"/filing/0001127602-23-022901#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2733.0,"shares_display":"2,733","price_per_share":0.63,"price_display":"0.63","price_state":"stated","total_value":1721.79,"total_display":"1,721.79","total_whole":"1,722","shares_owned_after":639666.0,"shares_owned_after_display":"639,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-18","scope":"insider"},{"id":7971152,"accession":"0001127602-23-022901","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-022901","line_url":"/filing/0001127602-23-022901#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2895.0,"shares_display":"2,895","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":1881.75,"total_display":"1,881.75","total_whole":"1,882","shares_owned_after":642399.0,"shares_owned_after_display":"642,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-18","scope":"insider"},{"id":8003212,"accession":"0001127602-23-022636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-022636","line_url":"/filing/0001127602-23-022636#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2629.0,"shares_display":"2,629","price_per_share":0.67,"price_display":"0.67","price_state":"stated","total_value":1761.43,"total_display":"1,761.43","total_whole":"1,761","shares_owned_after":645294.0,"shares_owned_after_display":"645,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-16","scope":"insider"},{"id":8003209,"accession":"0001127602-23-022636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-022636","line_url":"/filing/0001127602-23-022636#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2881.0,"shares_display":"2,881","price_per_share":0.63,"price_display":"0.63","price_state":"stated","total_value":1815.03,"total_display":"1,815.03","total_whole":"1,815","shares_owned_after":647923.0,"shares_owned_after_display":"647,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-16","scope":"insider"},{"id":8003206,"accession":"0001127602-23-022479","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-022479","line_url":"/filing/0001127602-23-022479#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2733.0,"shares_display":"2,733","price_per_share":0.67,"price_display":"0.67","price_state":"stated","total_value":1831.11,"total_display":"1,831.11","total_whole":"1,831","shares_owned_after":650804.0,"shares_owned_after_display":"650,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-14","scope":"insider"},{"id":8003203,"accession":"0001127602-23-022479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-022479","line_url":"/filing/0001127602-23-022479#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2790.0,"shares_display":"2,790","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":1897.2,"total_display":"1,897.20","total_whole":"1,897","shares_owned_after":653537.0,"shares_owned_after_display":"653,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-14","scope":"insider"},{"id":7927130,"accession":"0001127602-23-022281","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-022281","line_url":"/filing/0001127602-23-022281#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2798.0,"shares_display":"2,798","price_per_share":0.67,"price_display":"0.67","price_state":"stated","total_value":1874.66,"total_display":"1,874.66","total_whole":"1,875","shares_owned_after":656327.0,"shares_owned_after_display":"656,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-10","scope":"insider"},{"id":7927127,"accession":"0001127602-23-022281","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-022281","line_url":"/filing/0001127602-23-022281#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2810.0,"shares_display":"2,810","price_per_share":0.69,"price_display":"0.69","price_state":"stated","total_value":1938.9,"total_display":"1,938.90","total_whole":"1,939","shares_owned_after":659125.0,"shares_owned_after_display":"659,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-10","scope":"insider"},{"id":8699536,"accession":"0001127602-23-022219","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-022219","line_url":"/filing/0001127602-23-022219#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2857.0,"shares_display":"2,857","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":1942.76,"total_display":"1,942.76","total_whole":"1,943","shares_owned_after":661935.0,"shares_owned_after_display":"661,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-09","scope":"insider"},{"id":8699534,"accession":"0001127602-23-022219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-022219","line_url":"/filing/0001127602-23-022219#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2550.0,"shares_display":"2,550","price_per_share":0.69,"price_display":"0.69","price_state":"stated","total_value":1759.5,"total_display":"1,759.50","total_whole":"1,760","shares_owned_after":664792.0,"shares_owned_after_display":"664,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-09","scope":"insider"},{"id":8322104,"accession":"0001127602-23-022010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-022010","line_url":"/filing/0001127602-23-022010#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2679.0,"shares_display":"2,679","price_per_share":0.59,"price_display":"0.59","price_state":"stated","total_value":1580.61,"total_display":"1,580.61","total_whole":"1,581","shares_owned_after":667342.0,"shares_owned_after_display":"667,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-03","filed_date":"2023-08-04","scope":"insider"},{"id":8322098,"accession":"0001127602-23-022010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-022010","line_url":"/filing/0001127602-23-022010#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2587.0,"shares_display":"2,587","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":1345.24,"total_display":"1,345.24","total_whole":"1,345","shares_owned_after":670021.0,"shares_owned_after_display":"670,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-02","filed_date":"2023-08-04","scope":"insider"},{"id":8292965,"accession":"0001127602-23-021846","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-021846","line_url":"/filing/0001127602-23-021846#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2799.0,"shares_display":"2,799","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":1371.51,"total_display":"1,371.51","total_whole":"1,372","shares_owned_after":672608.0,"shares_owned_after_display":"672,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-02","scope":"insider"},{"id":8292958,"accession":"0001127602-23-021846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-021846","line_url":"/filing/0001127602-23-021846#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2676.0,"shares_display":"2,676","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":1338.0,"total_display":"1,338.00","total_whole":"1,338","shares_owned_after":675407.0,"shares_owned_after_display":"675,407","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-31","filed_date":"2023-08-02","scope":"insider"},{"id":7946660,"accession":"0001127602-23-021562","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-021562","line_url":"/filing/0001127602-23-021562#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2647.0,"shares_display":"2,647","price_per_share":0.47,"price_display":"0.47","price_state":"stated","total_value":1244.09,"total_display":"1,244.09","total_whole":"1,244","shares_owned_after":678083.0,"shares_owned_after_display":"678,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-07-31","scope":"insider"},{"id":7946657,"accession":"0001127602-23-021562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-021562","line_url":"/filing/0001127602-23-021562#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2791.0,"shares_display":"2,791","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":1423.41,"total_display":"1,423.41","total_whole":"1,423","shares_owned_after":680730.0,"shares_owned_after_display":"680,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-27","filed_date":"2023-07-31","scope":"insider"},{"id":8281999,"accession":"0000950170-23-035157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-035157","line_url":"/filing/0000950170-23-035157#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2609.0,"shares_display":"2,609","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":1356.68,"total_display":"1,356.68","total_whole":"1,357","shares_owned_after":683521.0,"shares_owned_after_display":"683,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-26","filed_date":"2023-07-27","scope":"insider"},{"id":8281993,"accession":"0000950170-23-035157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-035157","line_url":"/filing/0000950170-23-035157#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2803.0,"shares_display":"2,803","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":1401.5,"total_display":"1,401.50","total_whole":"1,402","shares_owned_after":686130.0,"shares_owned_after_display":"686,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-25","filed_date":"2023-07-27","scope":"insider"},{"id":8695447,"accession":"0000950170-23-034474","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-034474","line_url":"/filing/0000950170-23-034474#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2887.0,"shares_display":"2,887","price_per_share":0.54,"price_display":"0.54","price_state":"stated","total_value":1558.98,"total_display":"1,558.98","total_whole":"1,559","shares_owned_after":688933.0,"shares_owned_after_display":"688,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-24","filed_date":"2023-07-25","scope":"insider"},{"id":8695445,"accession":"0000950170-23-034474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-034474","line_url":"/filing/0000950170-23-034474#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2663.0,"shares_display":"2,663","price_per_share":0.61,"price_display":"0.61","price_state":"stated","total_value":1624.43,"total_display":"1,624.43","total_whole":"1,624","shares_owned_after":691820.0,"shares_owned_after_display":"691,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-21","filed_date":"2023-07-25","scope":"insider"},{"id":8148816,"accession":"0001127602-23-021132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-021132","line_url":"/filing/0001127602-23-021132#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2710.0,"shares_display":"2,710","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":1734.4,"total_display":"1,734.40","total_whole":"1,734","shares_owned_after":694483.0,"shares_owned_after_display":"694,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-20","filed_date":"2023-07-21","scope":"insider"},{"id":8148809,"accession":"0001127602-23-021132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-021132","line_url":"/filing/0001127602-23-021132#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2646.0,"shares_display":"2,646","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":1719.9,"total_display":"1,719.90","total_whole":"1,720","shares_owned_after":697193.0,"shares_owned_after_display":"697,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-21","scope":"insider"},{"id":8292932,"accession":"0001127602-23-021000","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-021000","line_url":"/filing/0001127602-23-021000#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2968.0,"shares_display":"2,968","price_per_share":0.56,"price_display":"0.56","price_state":"stated","total_value":1662.08,"total_display":"1,662.08","total_whole":"1,662","shares_owned_after":699839.0,"shares_owned_after_display":"699,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-18","filed_date":"2023-07-19","scope":"insider"},{"id":8292928,"accession":"0001127602-23-021000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-021000","line_url":"/filing/0001127602-23-021000#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2775.0,"shares_display":"2,775","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":1887.0,"total_display":"1,887.00","total_whole":"1,887","shares_owned_after":702807.0,"shares_owned_after_display":"702,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":8675428,"accession":"0001127602-23-020818","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-020818","line_url":"/filing/0001127602-23-020818#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1815.0,"shares_display":"1,815","price_per_share":0.59,"price_display":"0.59","price_state":"stated","total_value":1070.85,"total_display":"1,070.85","total_whole":"1,071","shares_owned_after":705582.0,"shares_owned_after_display":"705,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-14","filed_date":"2023-07-17","scope":"insider"},{"id":8675426,"accession":"0001127602-23-020818","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-020818","line_url":"/filing/0001127602-23-020818#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2646.0,"shares_display":"2,646","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":1031.94,"total_display":"1,031.94","total_whole":"1,032","shares_owned_after":707397.0,"shares_owned_after_display":"707,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-17","scope":"insider"},{"id":8075716,"accession":"0001127602-23-020658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-020658","line_url":"/filing/0001127602-23-020658#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2649.0,"shares_display":"2,649","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":1033.11,"total_display":"1,033.11","total_whole":"1,033","shares_owned_after":710043.0,"shares_owned_after_display":"710,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-13","scope":"insider"},{"id":8075711,"accession":"0001127602-23-020658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-020658","line_url":"/filing/0001127602-23-020658#line-1","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2731.0,"shares_display":"2,731","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":1010.47,"total_display":"1,010.47","total_whole":"1,010","shares_owned_after":712692.0,"shares_owned_after_display":"712,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-13","scope":"insider"},{"id":9212933,"accession":"0000950170-23-032737","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-032737","line_url":"/filing/0000950170-23-032737#line-2","is_derivative":false,"issuer_cik":"0001785288","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001785288","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2591.0,"shares_display":"2,591","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":984.58,"total_display":"984.58","total_whole":"985","shares_owned_after":715423.0,"shares_owned_after_display":"715,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-12","scope":"insider"},{"id":8475899,"accession":"0001127602-23-020571","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-23-020571","line_url":"/filing/0001127602-23-020571#line-4","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2591.0,"shares_display":"2,591","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":984.58,"total_display":"984.58","total_whole":"985","shares_owned_after":442696.0,"shares_owned_after_display":"442,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-11","scope":"insider"},{"id":9212934,"accession":"0000950170-23-032737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-032737","line_url":"/filing/0000950170-23-032737#line-1","is_derivative":false,"issuer_cik":"0001785288","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001785288","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2634.0,"shares_display":"2,634","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":921.9,"total_display":"921.90","total_whole":"922","shares_owned_after":718014.0,"shares_owned_after_display":"718,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-07","filed_date":"2023-07-12","scope":"insider"},{"id":8475892,"accession":"0001127602-23-020571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-020571","line_url":"/filing/0001127602-23-020571#line-2","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2634.0,"shares_display":"2,634","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":921.9,"total_display":"921.90","total_whole":"922","shares_owned_after":436196.0,"shares_owned_after_display":"436,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-07","filed_date":"2023-07-11","scope":"insider"},{"id":9212929,"accession":"0000950170-23-032731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-032731","line_url":"/filing/0000950170-23-032731#line-1","is_derivative":false,"issuer_cik":"0001785288","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001785288","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2773.0,"shares_display":"2,773","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":942.82,"total_display":"942.82","total_whole":"943","shares_owned_after":720648.0,"shares_owned_after_display":"720,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-06","filed_date":"2023-07-12","scope":"insider"},{"id":7866765,"accession":"0001127602-23-020474","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-23-020474","line_url":"/filing/0001127602-23-020474#line-3","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2773.0,"shares_display":"2,773","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":942.82,"total_display":"942.82","total_whole":"943","shares_owned_after":429739.0,"shares_owned_after_display":"429,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-06","filed_date":"2023-07-07","scope":"insider"},{"id":5346861,"accession":"0001127602-21-008932","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-21-008932","line_url":"/filing/0001127602-21-008932#line-6","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4202.0,"shares_display":"4,202","price_per_share":51.7591,"price_display":"51.76","price_state":"stated","total_value":217491.7382,"total_display":"217,491.74","total_whole":"217,492","shares_owned_after":308278.0,"shares_owned_after_display":"308,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":5346857,"accession":"0001127602-21-008932","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-21-008932","line_url":"/filing/0001127602-21-008932#line-5","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2688.0,"shares_display":"2,688","price_per_share":50.0038,"price_display":"50.00","price_state":"stated","total_value":134410.2144,"total_display":"134,410.21","total_whole":"134,410","shares_owned_after":312480.0,"shares_owned_after_display":"312,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":5346854,"accession":"0001127602-21-008932","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-21-008932","line_url":"/filing/0001127602-21-008932#line-4","is_derivative":false,"issuer_cik":"0001703647","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001703647","owner_cik":"0001785288","owner_name":"Lucchino David L.","owner_display_name":"Lucchino David L.","owner_url":"/insider/0001785288","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1255.0,"shares_display":"1,255","price_per_share":48.8536,"price_display":"48.85","price_state":"stated","total_value":61311.268,"total_display":"61,311.27","total_whole":"61,311","shares_owned_after":315168.0,"shares_owned_after_display":"315,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"}],"collapsed":true,"next_cursor":"2021-03-01|5346854","ledger_fault":false,"count":{"value":101,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":101,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":101},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001703647","name":"Korro Bio, Inc.","url":"/issuer/0001703647","role":"Director, Officer (President and CEO)","n_filings":48,"first_seen":"2020-04-17","last_seen":"2023-11-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001785288","retrieved_at":"2026-08-22T07:17:02+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}